HELLP syndrome--a pregnancy disorder with poor prognosis

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Hematology

Background:

• HELLP syndrome is a severe pregnancy-specific disorder characterized by hemolysis, elevated liver enzymes, and low platelet count.
• It often co-occurs with severe preeclampsia or eclampsia but can arise independently.
• The exact etiology and pathogenesis, including hepatological aspects, remain incompletely understood.

Purpose of the Study:

• To summarize the key features, diagnostic challenges, and management principles of HELLP syndrome.
• To highlight the importance of early recognition and multidisciplinary care in improving maternal and fetal prognosis.

Main Methods:

• Review of existing literature on HELLP syndrome.
• Analysis of clinical manifestations, diagnostic markers (LDH, platelet count), and etiological hypotheses.
• Discussion of management strategies and outcomes.

Main Results:

• HELLP syndrome presents with specific hematological and hepatic abnormalities.
• Serum LDH and platelet count are critical for assessing disease severity and hepatic dysfunction.
• Maternofetal mortality rates associated with HELLP syndrome are significant, ranging from 7.0-70.0% for perinatal and 1.0-24.0% for maternal mortality.

Conclusions:

• Prompt recognition and aggressive, multidisciplinary management are essential for improving outcomes in HELLP syndrome.
• Transfer to specialized obstetric centers is recommended for optimal patient care.
• Further research into the underlying pathogenesis may lead to improved therapeutic strategies.